HORIZON (OP-106): Melflufen plus dexamethasone in relapsed/refractory multiple myeloma (RRMM) refractory to pomalidomide and/or an anti-CD38 monoclonal antibody (mAb) - Final primary analysis Meeting Abstract
| Authors: | Richardson, P. G.; Oriol, A.; Larocca, A.; Bladé, J.; Cavo, M.; Rodriguez-Otero, P.; Leleu, X.; Norkin, M.; Nadeem, O.; Hiemenz, J. W.; Hassoun, H.; Touzeau, C.; Alegre, A.; Paner, A.; Maisel, C.; Mazumder, A.; Raptis, A.; Puig, N.; Harmenberg, J.; Byrne, C.; Thuresson, S.; Obermüller, J.; Mateos, M. V. |
| Abstract Title: | HORIZON (OP-106): Melflufen plus dexamethasone in relapsed/refractory multiple myeloma (RRMM) refractory to pomalidomide and/or an anti-CD38 monoclonal antibody (mAb) - Final primary analysis |
| Meeting Title: | 8th Annual Meeting of the Society of Hematologic Oncology (SOHO) |
| Keywords: | myeloma; multiple; mm; melflufen; melphalan flufenamide; peptide-drug conjugate |
| Journal Title: | Clinical Lymphoma, Myeloma and Leukemia |
| Volume: | 20 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 2020 Sep 9-12 |
| Meeting Location: | Houston, TX |
| ISSN: | 2152-2650 |
| Publisher: | Elsevier Inc. |
| Date Published: | 2020-09-01 |
| Start Page: | S295 |
| End Page: | S296 |
| Language: | English |
| ACCESSION: | WOS:000564055100311 |
| PROVIDER: | wos |
| DOI: | 10.1016/S2152-2650(20)30932-0 |
| Notes: | Meeting Abstract: MM-133 -- Due to COVID-19 pandemic, the conference was held virtually -- Source: Wos |
